Prader-Willi Syndrome Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies | Companies – Soleno Therapeutics, Levo Therapeutics, Pfizer, Novo Nordisk

June 26 08:52 2023
DelveInsight Business Research LLP
DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 

The Prader-Willi Syndrome market report provides current treatment practices, emerging drugs, Prader-Willi Syndrome market share of the individual therapies, and current and forecasted Prader-Willi Syndrome market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Prader-Willi Syndrome treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Prader-Willi Syndrome market.

Prader-Willi Syndrome Overview

Prader-Willi syndrome is a rare genetic disorder that results in a number of physical, mental, and behavioral problems. A key feature of Prader-Willi syndrome is a constant sense of hunger that usually begins at about 2 years of age. People with Prader-Willi syndrome want to eat constantly because they never feel full (hyperphagia), and they usually have trouble controlling their weight. Many complications of Prader-Willi syndrome are due to obesity.

Got queries? Click here to know more about the Prader-Willi Syndrome Market Landscape

Prader-Willi Syndrome Epidemiology Insights

  • In published reports on Prader-Willi syndrome (PWS), prevalence has been variously quoted as “about 1 in 25 000 live births.  Prader–Willi syndrome (PWS) is a rare genetic disorder with a birth incidence of 1/10,000 to 1/30,000 and an estimated prevalence of approximately 10,000 to 20,000 living individuals in the United States.

  •  It affects males and females equally, as well as all races and ethnicities  The estimates place the incidence between 1/10,000–30,000 individuals in the general population. In contrast, as per “Adult Prader-Willi Syndrome: An Update on Management by Luk Ho-Ming,” the incidence is about 1/15,000–25,000 live births. 

  • Although most of them are diagnosed during childhood, with the improvement of medical care, it is not uncommon for adult physicians to encounter PWS patients. 

  •  Reported prevalence rates for Prader-Willi syndrome range from 1 per 16,000 population in western Japan.

Prader-Willi Syndrome Epidemiology Segmentation 

  • Prader-Willi Syndrome diagnosed cases 

  • Prader-Willi Syndrome mutation cases 

  • Total Prader-Willi Syndrome clinical manifestation cases 

Prader-Willi Syndrome Market Outlook 

The Prader-Willi Syndrome market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Prader-Willi Syndrome market trends by analyzing the impact of current Prader-Willi Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of Prader-Willi Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Prader-Willi Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Prader-Willi Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.

Learn more by requesting for sample @ Prader-Willi Syndrome Market Trends

Prader-Willi Syndrome Key Companies 

  • Soleno Therapeutics 

  • Levo Therapeutics 

  • Pfizer

  • Novo Nordisk 

  • Radius Pharmaceuticals 

  • Rhythm Pharmaceuticals 

  • And many others 

 

Prader-Willi Syndrome Therapies 

  • RGH-706

  • DCCR

  • CSTI-500

  • ARD-101

  • Tesomet

  • Eutropin

And many others 

 

Table of Contents

  1.  Key Insights 

  2.  Report Introduction 

  3.  Executive Summary of Prader-Willi Syndrome  

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  The United States 

  7.  EU 5

  8.  Prader-Willi Syndrome Emerging Therapies

  9.  Prader-Willi Syndrome  Market Outlook

  10.  Market Access and Reimbursement of Therapies

  11.  Market Drivers 

  12.  Market Barriers 

  13.  Appendix

  14.  Prader-Willi Syndrome  Report Methodology

  15.  DelveInsight Capabilities

  16.  Disclaimer

Click here to read more about Prader-Willi Syndrome Market 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services